Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hellmann

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Cancer Treatment Reviews|March 1, 1981
A Clinical integrated therapeutic index (CITI) for the comparative evaluation of clinical trialsK Hellmann
Angiogenesis|October 1, 2003
Commentary on zinc ligand-disrupted recombinant human EndostatinK Hellmann
European Journal of Cancer|February 1, 1973
Metastasis and Triton WR 1339K Hellmann
Praxis Der Pneumologie|December 1, 1974
[Respiratory insufficiency]K Hellmann
Clinical & Experimental Metastasis|January 1, 1987
Razoxane, metastasis and adjuvant chemotherapyK Hellmann
BMJ (Clinical Research Ed.)|October 26, 1999
Preventing the cardiotoxicity of anthracyclines by dexrazoxaneK Hellmann
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1996
Cardioprotection by dexrazoxane (Cardioxane; ICRF 187): progress in supportive careK Hellmann
Antibiotics and Chemotherapy|January 1, 1978
RadiosensitizersK Hellmann
Clinical & Experimental Metastasis|April 23, 2003
Dynamics of tumour angiogenesis: effect of razoxane-induced growth rate slowdownK Hellmann
Progress in Clinical and Biological Research|January 1, 1986
Antimetastatic drugs: function and valueK Hellmann
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Cancer Treatment Reviews|March 1, 1981
A Clinical integrated therapeutic index (CITI) for the comparative evaluation of clinical trialsK Hellmann
Angiogenesis|October 1, 2003
Commentary on zinc ligand-disrupted recombinant human EndostatinK Hellmann
European Journal of Cancer|February 1, 1973
Metastasis and Triton WR 1339K Hellmann
Praxis Der Pneumologie|December 1, 1974
[Respiratory insufficiency]K Hellmann
Clinical & Experimental Metastasis|January 1, 1987
Razoxane, metastasis and adjuvant chemotherapyK Hellmann
BMJ (Clinical Research Ed.)|October 26, 1999
Preventing the cardiotoxicity of anthracyclines by dexrazoxaneK Hellmann
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1996
Cardioprotection by dexrazoxane (Cardioxane; ICRF 187): progress in supportive careK Hellmann
Antibiotics and Chemotherapy|January 1, 1978
RadiosensitizersK Hellmann
Clinical & Experimental Metastasis|April 23, 2003
Dynamics of tumour angiogenesis: effect of razoxane-induced growth rate slowdownK Hellmann
Progress in Clinical and Biological Research|January 1, 1986
Antimetastatic drugs: function and valueK Hellmann
Pageof 12